New York City will roll out more than 1,000 new 3-K seats this fall, with a focus on neighborhoods where "demand has outstripped supply," Mayor Zohran Mamdani said Tuesday. The new seats will be ...
Merck & Co.’s extensive clinical development scheme for its TROP2 antibody-drug conjugate (ADC) sac-TMT already includes 17 global phase 3 trials. But there’s one important missing piece. The New ...
shapeless is a type class and dependent type based generic programming library for Scala. This repository contains shapeless 3 for Scala 3. For shapeless 2 see its own repository. Please open issues ...
Georgia’s pre-K program was recently lauded as being one of the best and most far-reaching in the nation. One thing it’s missing: 3-year-olds. The state-funded preschool program has been around for 34 ...
Essential3 is the first positive Phase 3 program in essential tremor; ulixacaltamide has received FDA Breakthrough Therapy Designation, with data selected for plenary presentation at AAN 2026 Praxis ...
Alkermes initiated three pivotal 12-week, randomized, double-blind trials comparing alixorexton with placebo in narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Mechanistically, ...
Facebook Twitter WhatsApp SMS Email Print Copy article link Save Facebook Twitter WhatsApp SMS Email Print Copy article link Save Purchase Article Reprint Dubuque's Loras College will partner with a ...
Scott McLaughlin qualified on pole for last year’s race at St. Petersburg and finished fourth. On his return to the Floridian street course, the Team Penske driver captured pole once more and finished ...
This is a continuation of the previous article. I asked Gemini about the fact that I didn't notice MPLAB had been updated. The PC I am currently using is Windows 11, and I have been able to use the ...
Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...
BRISTOL, Tenn. (WJHL) – King University held an agreement signing on Tuesday with the Appalachian College of Pharmacy to unveil a new “3+3” accelerated pharmacy program. The program allows students to ...
Vorolanib in DURAVYU inhibits IL-6-mediated inflammation by blocking JAK receptors, showing sustained improvements in the phase 2 VERONA trial. The phase 3 program includes two non-inferiority trials, ...